CD103 engagement regulates intestinal IEL effector function
CD103 参与调节肠道 IEL 效应器功能
基本信息
- 批准号:10676560
- 负责人:
- 金额:$ 66.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-10 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntigensAutoimmunityBehaviorBindingBiological ProcessCD8B1 geneCarcinomaCeliac DiseaseCell LineCell physiologyCellsColorectalCommunicable DiseasesCuesCytoplasmic GranulesE-CadherinEpithelial CellsEpitheliumEventExhibitsExocytosisGene ExpressionGoalsGranzymeHomeostasisImmune System DiseasesImmune systemImmunityInfectionInfection ControlInflammatory Bowel DiseasesIntegrinsIntestinesInvadedInvestigationKnowledgeLigationLymphocyteLymphocyte ActivationLymphocyte CountLymphocyte FunctionMaintenanceMediatingMemoryMicrobeMissionModelingMolecularMucous MembraneNational Institute of Allergy and Infectious DiseasePathogenicityPlayPopulationPublic HealthRegulationResearchRestRoleSentinelSignal PathwaySignal TransductionSiteT-LymphocyteTherapeuticTissuesToxinTumor-Infiltrating LymphocytesUnited States National Institutes of HealthVirus DiseasesWorkcadherin 10cell motilitycombinatorialcytokinedietaryenteric infectionenteric pathogenexperimental studyhuman diseaseimproved outcomein vivoinsightintestinal barrierintestinal epitheliumintestinal homeostasisintraepithelialmicrobialmicroorganismmigrationnovelpathogenpreventrecruitresponse
项目摘要
PROJECT SUMMARY.
Mucosal surveillance of the intestinal barrier by tissue-resident lymphocytes is critical for preventing the
invasion of enteric pathogens and a necessary component of protective immunity. A single layer of epithelial
cells lines the intestinal tract and provides a physical barrier between microbes, dietary antigens, toxins and
the rest of the tissue. Therefore, the reactivation of lymphocytes at the intestinal barrier must be tightly
regulated, as too robust of a response could result in destruction of the epithelium leading to microbial
translocation and eventual autoimmunity, as observed in inflammatory bowel disease and celiac disease.
Tissue-resident intraepithelial lymphocytes (IELs) in the intestine provide a first line of defense against invading
microorganisms and the intestinal IEL compartment is composed of what has been termed induced and natural
IELs. Induced IELs are CD8ab+ TCRab+ tissue resident memory (Trm IELs) cells that are recruited to the
epithelial compartment following antigen exposure. In contrast, natural IELs are not MHC-restricted and include
CD8aa+ IELs expressing TCRgd (gd IELs). gd and Trm IELs represent the majority of the lymphocytes in the
intestinal epithelium and could serve both protective and pathogenic roles, yet mechanisms regulating their
activation during infection in vivo remain largely unexplored. CD103 (aEb7 integrin) is expressed by the majority
of gd and Trm IELs located in the intestine and at other barrier sites. CD103 binds to epithelial E-cadherin and
plays an important role in the recruitment and maintenance of tissue lymphocytes. However, the contribution of
CD103 to IEL functionality within the intestine during infection has not been addressed. Successful completion
of the proposed aims will provide fundamental insight into the molecular mechanisms by which CD103 ligation
to E-cadherin promotes (1) the motility and activation of Trm and (2) gd IELs and the role of CD103 in
promoting protective responses to enteric infection. These studies will uncover novel mechanisms by which
direct interaction between IELs and epithelial cells contribute to host immunity and further define the molecular
cues regulating sentinel lymphocyte populations in mucosal homeostasis and infection.
项目摘要。
通过组织居民淋巴细胞对肠道屏障的粘膜监测对于防止
入侵肠道病原体和保护性免疫的必要组成部分。一层上皮
细胞在肠道上排成一条肠道,并在微生物,饮食抗原,毒素和
其余的组织。因此,必须紧密地在肠屏障处的淋巴细胞重新激活
受调节,由于反应太强大可能会导致上皮破坏导致微生物
如在炎症性肠病和腹腔疾病中所观察到的,易位和最终自身免疫性。
肠内的组织内淋巴细胞(IEL)提供了针对入侵的第一道防御
微生物和肠道IEL室由所谓的诱导和自然组成
IELS。诱导的IEL是招募到
抗原暴露后的上皮室。相比之下,天然IEL不受MHC的限制,包括
CD8AA+ IEL表达TCRGD(GD IELS)。 GD和TRM IEL代表大多数淋巴细胞
肠上皮,可以发挥保护性和致病作用,但调节其机制
体内感染期间的激活在很大程度上仍未开发。 CD103(AEB7整合素)由多数表达
GD和TRM IEL位于肠和其他屏障站点。 CD103与上皮E-钙粘蛋白和
在组织淋巴细胞的募集和维持中起着重要作用。但是,
尚未解决感染过程中肠内IEL功能的CD103。成功完成
拟议的目标将提供对CD103结扎的分子机制的基本见解
到E-钙粘蛋白促进(1)TRM和(2)GD IELS的运动和激活以及CD103在
促进对肠道感染的保护性反应。这些研究将发现新的机制
IELS和上皮细胞之间的直接相互作用有助于宿主免疫,并进一步定义分子
提示在粘膜稳态和感染中调节前哨淋巴细胞种群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tessa Bergsbaken其他文献
Tessa Bergsbaken的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tessa Bergsbaken', 18)}}的其他基金
Differentiation and function of intestinal tissue-resident memory T cells
肠道组织驻留记忆T细胞的分化和功能
- 批准号:
10028676 - 财政年份:2020
- 资助金额:
$ 66.02万 - 项目类别:
Differentiation and function of intestinal tissue-resident memory T cells
肠道组织驻留记忆T细胞的分化和功能
- 批准号:
10189514 - 财政年份:2020
- 资助金额:
$ 66.02万 - 项目类别:
Differentiation and function of intestinal tissue-resident memory T cells
肠道组织驻留记忆T细胞的分化和功能
- 批准号:
10684315 - 财政年份:2020
- 资助金额:
$ 66.02万 - 项目类别:
Mobilization of tissue-resident lymphocytes during secondary infection
继发感染期间组织驻留淋巴细胞的动员
- 批准号:
10056391 - 财政年份:2020
- 资助金额:
$ 66.02万 - 项目类别:
Differentiation and function of intestinal tissue-resident memory T cells
肠道组织驻留记忆T细胞的分化和功能
- 批准号:
10466863 - 财政年份:2020
- 资助金额:
$ 66.02万 - 项目类别:
Defining the inflammatory signals that regulate CD8+ T cell recruitment and function in colorectal cancer
定义调节结直肠癌中 CD8 T 细胞募集和功能的炎症信号
- 批准号:
9759795 - 财政年份:2017
- 资助金额:
$ 66.02万 - 项目类别:
相似国自然基金
基于表达MHC-肽嵌合抗原受体T细胞治疗自身免疫疾病的策略和机制研究
- 批准号:81901643
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
特异性乙酰胆碱能受体嵌合抗原受体T细胞(AChR-CAR T)治疗实验性自身免疫性重症肌无力鼠模型的有效性和机制研究
- 批准号:81870988
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
滤泡辅助性T细胞在CTLA-4Ig诱导Graves病免疫耐受中的作用及机制研究
- 批准号:81801621
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
I型主要组织相容性复合体参与1型糖尿病异常自身抗原呈递的机制研究
- 批准号:81700691
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
SOX1参与副肿瘤性抗GABABR脑炎抗原表达机制的研究
- 批准号:81771313
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
相似海外基金
Delineating mechanisms underlying the enhanced stability and functionality of CD2-KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation
描述 CD2-KO Tregs 和嵌合抗原受体 (CAR) Tregs 稳定性和功能增强的机制及其在异种移植中的应用
- 批准号:
10646753 - 财政年份:2023
- 资助金额:
$ 66.02万 - 项目类别:
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence
B 细胞受体序列抗原特异性高通量作图技术
- 批准号:
10734412 - 财政年份:2023
- 资助金额:
$ 66.02万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 66.02万 - 项目类别:
Mitochondrial Membrane Dynamics in Th17 Cells
Th17 细胞的线粒体膜动力学
- 批准号:
10733013 - 财政年份:2023
- 资助金额:
$ 66.02万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 66.02万 - 项目类别: